Moderna stock (MRNA) slips in premarket after 17% surge — here’s what investors are watching next
New York, January 14, 2026, 05:03 (ET) — Premarket Moderna shares fell roughly 1% in early trading Wednesday, following a strong jump the previous session. The stock stood at $39.20, down 40 cents from Tuesday’s close of $39.60. (Investing.com) This move is crucial as Moderna struggles to reassure investors it can establish steady footing now that demand for COVID shots has dropped. The market has shown little tolerance for vaccine makers missing their own demand forecasts, even slightly. This week’s price volatility raises the stakes on upcoming numbers and timelines. Traders are watching closely to confirm if cost cuts hold